The RetroDUR and Capsules newsletters are published by the BMS Pharmacy program in conjunction with the DUR vendor for prescribers and pharmacy providers. This letter provides information on a number of topics of interest including current clinical drug information and Bureau policy updates.
2023 Newsletters
RetroDUR 2023 Quarter 4
RetroDUR 2023 Quarter 3
RetroDUR 2023 Quarter 2
RetroDUR 2023 Quarter 1
2022 Newsletters
RetroDUR 2022 Quarter 4
RetroDUR 2022 Quarter 3
RetroDUR 2022 Quarter 2
RetroDUR 2022 Quarter 1
2021 Newsletters
RetroDUR 2021 Quarter 3
RetroDUR 2021 Quarter 2
RetroDUR 2021 Quarter 1
2020 Newsletters
RetroDUR 2020 Quarter 4
RetroDUR 2020 Quarter 3
RetroDUR Winter
2019 Newsletters
RetroDUR, Summer
2018 Newsletters
DUR Capsules, Quarter 2
DUR Capsules, Quarter 1
2017 Newsletters
DUR Capsules, Quarter 4
DUR Capsules, Quarter 3
DUR Capsules, June 2017
DUR Capsules, March 2017
Archived Newsletters
2016 Newsletters
DUR Capsules, June 2016
DUR Capsules, March 2016
2015 Newsletters
DUR Capsules, December 2015
Sleep Hygiene, July 2015
Opioid Pain Relief Utlization in WV, March 2015
2014 Newsletters
Preferred Drug List Updates December 2014
WV Medicaid Lock-In Program August, 2014
Biologic Immunomodulators June 2014
Pediculosis Capitus Treatment Review for Clinicians March 2014
2013 Newsletters
Preferred Drug List Updates December, 2013
Focus on Atypical Antipsychotics February, 2013
2012 Newsletters
Incretin-Based Therapies in the Management of Type 2 Diabetes November, 2012
New Oral Anticoagutiants June, 2012
Treatment of Attention-Deficit/Hyperactivity Disorder April, 2012
2011 Newsletters
Bacterial Conjunctivitis November, 2011
New Prescribing Recommendations for Simvastatin June, 2011
2010 Newsletters
Considerations when Using Controlled Substances to Treat Chronic Pain
DUR Capsules - Prior Authorization of Suboxone® or Subutex® Spring, 2010
